skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection

Journal Article · · Virology
 [1];  [2];  [2];  [2];  [3];  [2];  [2];  [3];  [2]
  1. Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 (United States) and Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, MD 20892 (United States)
  2. Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 (United States)
  3. Department of Medicine, Molecular Microbiology, Pathology and Immunology Washington University School of Medicine, St. Louis, MO 63110 (United States)

West Nile virus (WNV) is a neurotropic flavivirus within the Japanese encephalitis antigenic complex that is responsible for causing West Nile encephalitis in humans. The surface of WNV virions is covered by a highly ordered icosahedral array of envelope proteins that is responsible for mediating attachment and fusion with target cells. These envelope proteins are also primary targets for the generation of neutralizing antibodies in vivo. In this study, we describe a novel approach for measuring antibody-mediated neutralization of WNV infection using virus-like particles that measure infection as a function of reporter gene expression. These reporter virus particles (RVPs) are produced by complementation of a sub-genomic replicon with WNV structural proteins provided in trans using conventional DNA expression vectors. The precision and accuracy of this approach stem from an ability to measure the outcome of the interaction between antibody and viral antigens under conditions that satisfy the assumptions of the law of mass action as applied to virus neutralization. In addition to its quantitative strengths, this approach allows the production of WNV RVPs bearing the prM-E proteins of different WNV strains and mutants, offering considerable flexibility for the study of the humoral immune response to WNV in vitro. WNV RVPs are capable of only a single round of infection, can be used under BSL-2 conditions, and offer a rapid and quantitative approach for detecting virus entry and its inhibition by neutralizing antibody.

OSTI ID:
20779461
Journal Information:
Virology, Vol. 346, Issue 1; Other Information: DOI: 10.1016/j.virol.2005.10.030; PII: S0042-6822(05)00647-1; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0042-6822
Country of Publication:
United States
Language:
English